Is Melanotan 2 legal? What regulators have said
No regulator checked has approved Melanotan II. What authorities in the US, UK, Australia, Ireland, Denmark, Canada and Norway say about selling it.
Peptio Research
On this page10
No regulator checked for this page has approved a product containing Melanotan II. Where an authority has said so in terms, selling or supplying it is unlawful: Canada and Australia state that as a general rule and apply it to Melanotan II; in the United Kingdom the rule reaches injectable products and pens, and nasal sprays only when sold with medical claims; and in the United States, FDA told one seller in 2007 that selling it without approval violated federal law, and that seller was later convicted and debarred. None of the authority documents opened for this page says that buying or possessing it is, in itself, an offence. The one document that goes further than selling is from Norwegian Customs, which says it is illegal to import into Norway, and for a buyer in Norway ordering from abroad, that is the same act. An absence of a statement is not permission. The law differs by country, and this page reports what each authority has published, not legal advice.
Four questions are easy to blur, and the sections below keep them apart: whether a product is approved, whether selling or supplying it is unlawful, whether importing it is unlawful, and whether holding it is. What has been measured about Melanotan II in people, and the case reports of harm, are on the Melanotan II page.
United States
FDA treats Melanotan II as an unapproved new drug. A debarment order in the Federal Register of 14 November 2016 says the debarred man's company "advertised MII, an unapproved new drug, as an injectable tanning product through an internet Web site" 1. FDA's earlier proposal to debar him, undated on its face, records a warning letter "On or about August 30, 2007", which "concluded that the sale of MII without an FDA approved application violated the FDCA", a guilty plea to two counts of federal conspiracy, and that "you admitted that Melanocorp sold MII, a drug that had not been approved by the FDA" 2. The enforcement on record is against one seller: a criminal conviction followed by debarment.
On compounding, the documents point in two directions. FDA's page on bulk drug substances that may present significant safety risks, current as of 22 April 2026, lists Melanotan II among substances nominated but withdrawn 3. A withdrawn nomination is neither an approval nor a ban. Melanotan II has no entry in any category of FDA's 503A list updated 14 May 2026 4, yet FDA's advisory committee page, current as of 15 April 2026, lists it among substances "being considered for inclusion on the 503A bulks list", at a meeting to be held before the end of February 2027 5. No FDA document found explains the gap. None of these documents addresses possession.
United Kingdom
The MHRA's position comes from two freedom of information replies, which are answers to individual requests, not formal guidance. They differ.
The first, dated 20 December 2021, says the question is decided case by case, that injectable tanning products containing melanotan II "are not automatically medicines", and that nasal sprays without medicinal claims "will not generally be regulated as medicinal products" 6.
The second, FOI 24/274, dated 17 April 2024, is the most recent position found. It says: "Products containing Melanotan II are classified as medicines if they are injectable or pens. If a product contains Melanotan II and is in the form of a nasal spray, it will be determined as a medicine only if sold with claims to treat or prevent disease." 7 On injectables, that is a firmer line than the 2021 wording. On nasal sprays the two replies agree.
The 2024 reply adds that "the sale, supply and advertising of unauthorised medicines is not permitted under the Human Medicines Regulations", and that "the MHRA has repeatedly taken action to remove Melanotan products from the market for over 10 years and will continue to do so where products fall within the definition of a medicinal product" 7. It also reports 16 UK suspected adverse drug reaction reports for Melanotan II received between 1 January 2012 and 31 December 2022, noting that the inclusion of a report "does not necessarily mean that the events were caused by the product" 7. Neither reply addresses possession.
Australia
A TGA safety advisory published on 17 August 2026 says: "Melanotan II is a prescription-only medicine in Australia and is not approved for use as a tanning agent. There are currently no products containing Melanotan II included in the Australian Register of Therapeutic Goods (ARTG) or approved for supply in Australia." 8 It states as a general rule that "the supply and advertising of unapproved therapeutic goods in Australia is prohibited unless a relevant exemption applies" 8.
The advisory records that the TGA issued 27 infringement notices, totalling $101,412, to a New South Wales individual "for the alleged unlawful supply of the Melanotan II products to Australian consumers", and that the notices were paid in May 2026 8. It also sets out the maximum penalties under the therapeutic goods law in general: civil penalties of up to $1.82 million per breach for individuals or $18.2 million per breach for corporations, and criminal penalties of up to 7 years imprisonment 8. Those are ceilings for the Act as a whole, not penalties specific to Melanotan II, and they were not imposed in this case.
The advisory does not say what being prescription-only means for a person who buys or holds Melanotan II, and this page does not infer it. The TGA's website could not be reached from the environment used to research this page; the advisory was read in a browser by a person on 8 October 2026 8.
Ireland
In a press release of 28 March 2024 on illegal medicines detained in 2023, the HPRA reported "a concerning upward trend in detentions of Melanotan 2, an unregulated substance promoted as a self-tanning aid" 9. The same release says that the supply of prescription medicines sourced online and from unauthorised sources into and within Ireland is illegal 9. That sentence is about those products in general; it is not an HPRA ruling on Melanotan 2 in particular.
Denmark
The Danish Medicines Agency warned in 2008 that "The medicinal product Melanotan is not licensed in Denmark, Europe or the United States", and that "The illegal medicinal product may be handed over to a pharmacy for destruction" 10. A warning of 20 June 2011 repeats that "The product is not authorised in Denmark, Europe or the United States" 11. Both pages say only "Melanotan" and never specify Melanotan I or II. The statement about Europe is the Danish agency's; no document from the EU medicines regulator naming Melanotan II was found for this page.
Canada
A Health Canada advisory of 1 August 2025 about products seized from one seller lists "Melanotan 1" and "Melanotan II" among them, and says "Health Canada has not authorized any of the products that were seized or sold on the company's website" 12. It states: "Selling unauthorized drugs is illegal in Canada." 12 Its advice to consumers, "Do not buy or use unauthorized drugs", is advice; the advisory does not say that buying is an offence 12.
Norway
In a decision dated 9 January 2026 (case 25/34799-15), the Norwegian Medical Products Agency (Direktoratet for medisinske produkter, DMP) ordered a private individual to stop advertising melanotan and retatrutide. It wrote: "Melanotan er ikke et godkjent legemiddel i Norge." That translates as "Melanotan is not an approved medicinal product in Norway." It went on: "Reklame for Retatrutid og melanotan er dermed ikke tillatt, da ingen av disse innehar markedsføringstillatelse i Norge", meaning that advertising either is not permitted because neither holds a marketing authorisation in Norway 13. The translations are this site's. The agency's own sentences say "melanotan" without a number.
Norwegian Customs goes further than any other authority found. In a news item published on 8 May 2025, it reports stopping close to 2,500 units of melanotan since 2023, and says melanotan "er ikke godkjent som legemiddel og dermed ulovlig å importere til Norge", that is, it is not approved as a medicine and therefore illegal to import into Norway 14. It is the only authority document found for this page that calls importing illegal in terms.
Countries not covered
No primary document from the medicines regulators of Sweden, Germany, France, the Netherlands, Belgium or New Zealand could be retrieved for this page, so it says nothing about them. No authority document found here supports a statement that Melanotan II is banned throughout the European Union, or that it is legal to buy for research purposes.
Sport
Melanotan II's status under anti-doping rules was not established from a primary document for this page.
Peptides covered
Research areas
Sources
- 1. Edward Manookian (Also Known as Ed Manning): Debarment Order. Federal Register (Food and Drug Administration). 2016. View source(open access)
- 2. Proposal to Debar; Notice of Opportunity for Hearing, Docket No. FDA-2015-N-4169 (Edward Manookian, Melanocorp). U.S. Food and Drug Administration, Office of Enforcement & Import Operations. 2015. View source(open access)
- 3. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. U.S. Food and Drug Administration. 2026. View source(open access)
- 4. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act, updated May 14, 2026. U.S. Food and Drug Administration. 2026. View source(open access)
- 5. Meeting of the Pharmacy Compounding Advisory Committee (to be scheduled before the end of February 2027). U.S. Food and Drug Administration. 2026. View source(open access)
- 6. FOI 21/1237: Yellow Card reports for melanotan II products, 2011 to 2021. Medicines and Healthcare products Regulatory Agency. 2021. View source(open access)
- 7. FOI 24/274: Side effects reports of melanotan II products. Medicines and Healthcare products Regulatory Agency. 2024. View source(open access)
- 8. Melanotan II tanning peptide products found to be inconsistently dosed. Therapeutic Goods Administration. 2026. View source(open access)
- 9. Close to 900,000 units of illegal medicines detained by the HPRA in 2023. Health Products Regulatory Authority (Ireland). 2024. View source(open access)
- 10. Warning against the product Melanotan. Danish Medicines Agency (Laegemiddelstyrelsen). 2008. View source(open access)
- 11. Warning against the tanning product Melanotan. Danish Medicines Agency (Lægemiddelstyrelsen). 2011. View source(open access)
- 12. Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks. Health Canada (Recalls and safety alerts). 2025. View source(open access)
- 13. Vedtak om palegg om stans av ulovlig reklame for melanotan og retatutrid (case 25/34799-15). Direktoratet for medisinske produkter (Norway). 2026. View source(open access)
- 14. Tolletaten advarer mot Barbie-dop og slankemidler. Tolletaten (Norwegian Customs). 2025. View source(open access)